For Alzheimer's Agitation, Promising News from Rexulti (Brexpiprazole)

Rexulti (brexpiprazole) shares positive trial results for treating agitation in Alzheimer's. Following this a bumpy road for another Alzheimer's drug candidate that could supplant the need for antipsychotics to treat behavioral Alzheimer's symptoms, this could be the first such drug approved — if its safety and efficacy data stay on track.

Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for

Decision on Brexpiprazole for Alzheimer's Agitation Due in May

Speaking Alzheimer's: A Glossary of Common Terms

FDA Approves First Drug to Treat Agitation Symptoms Associated

Brexpiprazole (Rexulti): Uses, Side Effects, Warnings & More - GoodRx

Lundbeck and Otsuka reports positive data from phase 3 trial of

Rexulti Full Prescribing Information, Dosage & Side Effects

Lundbeck, Otsuka drug cut agitation in Alzheimer's patients

Why REXULTI® (brexpiprazole) agitation that may happen with